Replies to post #8438 on RespireRx Pharmaceuticals Inc (fka RSPI)

[laker9029]

<Access to capital opens and closes.>

Correct as well.

<It's better to take when you can get it.>

Apparently not in this case, the overhang of the options coupled with the jolt caused by the surprise PIPE in advance of expected good news has opened the door for the warrant holders to short against the box and drive the price down dramatically -- which is exactly what is happening today.

Management does have responsibilty to consider shareholder value overall and trading $30 million in market cap to buy 14.9 million in cash is looking pretty bad right now.

L

[Aiming4]

WMG2 - excellent thoughts, I agree.

I feel quite stupid in retrospect for not acting on my belief that it was quite reasonable to think Cortex would be seriously contemplating a financing for the reasons you listed, but I had thought a financing might at least wait until the IND was filed and/or approved.

I'm not defending this financing, because I don't know the details or rationale behind it.

But when I put my CEO glasses on and take my individual investor glasses off, there are a lot of separate reasons Cortex could have combined together to make this a rational but painful decision.